Abstract:AIM To evaluate the prognostic factors and tumor stages of the 7(th) edition TNM classification for esophageal cancer. METHODS In total, 1033 patients with esophageal squamous cell carcinoma (ESCC) who underwent surgical resection with or without (neo)adjuvant therapy between January 2003 and June 2012 at the Thoracic Surgery Department II of the Beijing Cancer Hospital, Beijing, China were included in this study. The following eligibility criteria were applied: (1) squamous cell carcinoma of the esophagus or gastroesophageal junction identified by histopathological examination; (2) treatment with esophagectomy plus lymphadenectomy with curative intent; and (3) complete pathologic reports and follow-up data. Patients who underwent non-curative (R1) resection and patients who died in hospital were excluded. Patients who received (neo)adjuvant therapy were also included in this analysis. All patients were restaged using the 7(th) edition of the Union for International Cancer Control and the American Joint Committee on Cancer TNM staging systems. Univariate and multivariate analyses were performed to identify the prognostic factors for survival. Survival curves were plotted using the Kaplan-Meier method, and the log-rank test was used to evaluate differences between the subgroups. RESULTS Of the 1033 patients, 273 patients received (neo)adjuvant therapy, and 760 patients were treated with surgery alone. The median follow-up time was 51.6 mo (range: 5-112 mo) and the overall 5-year survival rate was 36.4%. Gender, "pT" and "pN" descriptors, (neo)adjuvant therapy, and the 7(th) edition TNM stage grouping were independent prognostic factors in the univariate and multivariate analyses. However, neither histologic grade nor cancer location were independent prognostic factors in the univariate and multivariate analyses. The 5-year stage-based survival rates were as follows: IA, 84.9%; IB, 70.9%; IIA, 56.2%; IIB, 43.3%; IIIA, 37.9%; IIIB, 23.3%; IIIC,12.9% and IV, 3.4%. There were significant differences between each adjacent staging classification. Moreover, there were significant differences between each adjacent pN and pM subgroup. According to the pT descriptor, there were significant differences between each adjacent subgroup except between pT3 and pT4 (P = 0.405). However, there was no significant difference between each adjacent histologic grade subgroup and between each adjacent cancer location subgroup. CONCLUSION The 7(th) edition is considered to be valid for patients with resected ESCC. However, the histologic grade and cancer location were not prognostic factors for ESCC.

Do Tumor Grade and Location Affect Survival in Esophageal Squamous Cell Carcinoma? Survival Analysis of 302 Cases of Pt3n0m0 Esophageal Squamous Cell Carcinoma

Do Tumor Location and Grade Affect Survival in Pt2n0m0 Esophageal Squamous Cell Carcinoma?

Tumor location does not impact long-term survival in patients with operable thoracic esophageal squamous cell carcinoma in China.

Does Tumour Location Influence Postoperative Long-Term Survival in Patients with Oesophageal Squamous Cell Carcinoma?

The Impact of Tumor Cell Differentiation on Survival of Patients with Resectable Esophageal Squamous Cell Carcinomas.

Impact of Esophageal Cancer Staging on Overall Survival and Disease-Free Survival Based on the 2010 AJCC Classification by Lymph Nodes.

Prognostic factors and outcome for patients with esophageal squamous cell carcinoma underwent surgical resection alone: evaluation of the seventh edition of the American Joint Committee on Cancer staging system for esophageal squamous cell carcinoma.

Validation of the 7th edition American Joint Committee on cancer staging system for esophageal squamous cell carcinoma.

Postchemoradiotherapy Pathologic Stage Classified by the American Joint Committee on the Cancer Staging System Predicts Prognosis of Patients with Locally Advanced Esophageal Squamous Cell Carcinoma

Pathological stage after neoadjuvant chemoradiation and esophagectomy superiorly predicts survival in patients with esophageal squamous cell carcinoma

Evaluation of the 7thedition of the TNM Classification in Patients with Resected Esophageal Squamous Cell Carcinoma

Prognostic Factors in Patients with Thoracic Esophageal Carcinoma Staged Pt1-4An0m0 Undergone Esophagectomy with Three-Field Lymphadenectomy.

Study on the clinicopathological variables affecting postoperative survival of pT1b-4aN0M0 thoracic esophageal squamous cell carcinoma

[Clinical Implications of the New TNM Staging System for Thoracic Esophageal Squamous Cell Carcinoma].

Survival analysis of patients with pathologic T2-3N0 squamous cell carcinoma of thoracic esophagus after esophagectomy

Prognosis of esophageal squamous cell carcinoma patients with preoperative radiotherapy: Comparison of different cancer staging systems

Comparison of the Prognostic Difference Between Yptnm and Equivalent Ptnm Stages in Esophageal Squamous Cell Carcinoma Based on the 8th Edition of AJCC Classification

PS02.050: TUMOR LOCATION IS AN INDEPENDENT PROGNOSTIC FACTOR OF ESOPHAGEAL ADENOCARCINOMA BASED ON THE EIGHTH EDITION OF TNM STAGING SYSTEM IN CHINESE PATIENTS

Prognostic Analysis of the Patients with Stage-Iii Esophageal Squamous Cell Carcinoma after Radical Esophagectomy.

The N-Classification for Esophageal Cancer Staging: Should it be Based on Number, Distance, or Extent of the Lymph Node Metastasis?

Associated Factors and Prognosis of Residual Cancer after Esophagectomy for Squamous Cell Carcinoma of the Esophagus